CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate Public Health Vaccine, LLC. will partner with Crozet Biopharma to develop the Nipah vaccine candidateUp to $9 million of this funding will go to Resilience, Inc., to support manufacturing and stockpiling of [...]
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Resilience Inc. PRESS RELEASE UPDATED: AUG 7, 2019 CINCINNATI, August 7, 2019 (Newswire.com) - Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with Resilience, Inc. to manufacture a novel universal influenza vaccine. The vaccine, based on technology [...]
Privacy Policy Website Privacy Policy Resilience, Inc. Revised as of 21stJune 2019 By visiting our website, you are accepting the practices described in this Privacy Policy We have created this privacy policy to demonstrate our firm commitment to the privacy of our visitors and customers. We are committed to respecting [...]
Disclaimer/Disclosure Resilience does not warrant that the information contained in this Website or Blog is accurate, complete, current, or useful. The information in this Website and Blog is provided without any express or implied warranties, including but not limited to warranties of merchantability, fitness for a particular purpose or noninfringement. The [...]
Cookie Policy Cookie policy with link to Privacy policy Resilience uses cookies to analyze website traffic to improve website functionality and provide you with a better browsing experience. Information about the use of cookies on this site and how you can decline them is provided in our privacy policy. By using [...]
A Retrospective Introduction Resilience is a trusted biopharmaceutical partner, providing high quality products and services for over 15 years, on-time and on-budget. Resilience, Inc. (Resilience) is a privately owned, US-based, mid-sized, Commercial Development and Manufacturing Organization (CDMO) providing services from sequence to Phase II, to both government and commercial [...]
Tomic MT, Espinoza Y, Martinez Z, et al. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Toxins 2019, 11(4), 208; https://doi.org/10.3390/toxins11040208. Read More >
Resilience Wins Two Department of Defense Awards Totaling More Than $135 Million ALACHUA, Fla.--(BUSINESS WIRE)--Resilience, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two [...]
Resilience Appoints Vaccines and Biologics Manufacturing Industry Veteran, Brandon Brega, as Chief Operating Officer ALACHUA, Fla.--(BUSINESS WIRE)--Resilience, Inc., a biologics contract development and manufacturing organization (CDMO), announced today the appointment of vaccines and biologics manufacturing industry expert, Brandon Brega, to the position of Chief Operating Officer, effective immediately. In this [...]
Resilience to Present at the 30thAnnual Piper Jaffray Healthcare Conference ALACHUA, Fla., November 20, 2018 - - Resilience, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that management will present at the 30thAnnual Piper Jaffray Healthcare conference, to be held at the Lotte New York Palace hotel, [...]